SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-005351
Filing Date
2009-01-30
Accepted
2009-01-30 16:11:00
Documents
9
Period of Report
2009-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-4281_18k.htm 8-K 40382
2 EX-1.3 a09-4281_1ex1d3.htm EX-1.3 141550
3 EX-4.4 a09-4281_1ex4d4.htm EX-4.4 117175
4 EX-5.1 a09-4281_1ex5d1.htm EX-5.1 14878
5 EX-10.67 a09-4281_1ex10d67.htm EX-10.67 204510
6 EX-10.68 a09-4281_1ex10d68.htm EX-10.68 12518
7 EX-99.1 a09-4281_1ex99d1.htm EX-99.1 7989
8 GRAPHIC g42811ke01i001.jpg GRAPHIC 5700
9 GRAPHIC g42811ke03i001.jpg GRAPHIC 5636
  Complete submission text file 0001104659-09-005351.txt   556540
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 09558445
SIC: 2834 Pharmaceutical Preparations